Radiolabeled Nanocarriers as Theranostics-Advancement from Peptides to Nanocarriers.
Sign Up to like & getrecommendations! Published in 2022 at "Small"
DOI: 10.1002/smll.202200673
Abstract: Endogenous targeted radiotherapy is emerging as an integral modality to treat a variety of cancer entities. Nevertheless, despite the positive clinical outcome of the treatment using radiolabeled peptides, small molecules, antibodies, and nanobodies, a high… read more here.
Keywords: advancement peptides; peptides nanocarriers; theranostics advancement; radiolabeled nanocarriers ... See more keywords